Skip to content
NORR
Science + Research

West Pharmaceutical Services

West Pharmaceutical Services, a global innovator of injectable drug therapies, identified 250 Radnor Life Science Centre as the ideal location to design a lab within the coveted Philadelphia Cellicon Valley corridor, the mecca for cell and gene therapy research.

Client West
Size 20,000 SF (1,858 SM)
Location Radnor, PA, US
Date 2023
Rating
LEED Certified
Laboratory workspace featuring research benches, equipment, and natural daylight.

Challenge

Creating a hybrid lab and workplace environment required balancing flexibility, collaboration, and mobility with the technical, safety, and infrastructure requirements of a modern research facility. The design also needed to support the safe handling of biological and biomedical materials while accommodating future growth.

Solution

Our design combines BSL-1 and BSL-2 laboratories with open workspaces and collaboration zones that encourage interaction between research teams. Floor-to-ceiling glazing, acoustic ceiling features, integrated lighting, and a recurring hexagonal pattern create a bright, flexible environment supported by specialized research infrastructure and future expansion space.

Outcome

The R&D lab supports the company’s $40 million global expansion to accelerate new therapies for partners and patients. Designed around evolving models of collaboration, the LEED® Certified facility helps attract talent, investment, and engagement with the broader research community.

Open café and collaboration area with seating, worktables, and geometric ceiling lighting features.

Dedicated outdoor air units, acid neutralization systems, consumables storage, and waste disposal areas support the safe operation of BSL-1 and BSL-2 laboratories.

Meeting room with glass walls, collaborative workspaces, and geometry patterns.
Open workplace overlooking laboratory spaces with collaborative seating and floor-to-ceiling windows.
Collaborative lounge with meeting space, feature lighting, and laboratory views.

Still scrolling? See what’s next.